Express Scripts Holding Company (NASDAQ: ESRX) recently received a number of ratings updates from brokerages and research firms:
Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded up 0.37% on Tuesday, reaching $64.84. The company’s stock had a trading volume of 3,382,522 shares. Express Scripts Holding Company has a 52-week low of $63.22 and a 52-week high of $80.02. The stock has a market cap of $39.27 billion, a P/E ratio of 12.03 and a beta of 0.92. The firm’s 50 day moving average is $68.09 and its 200-day moving average is $70.43.
Express Scripts Holding Company (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, February 14th. The company reported $1.88 EPS for the quarter, beating the Zacks’ consensus estimate of $1.87 by $0.01. Express Scripts Holding Company had a return on equity of 24.99% and a net margin of 2.70%. The firm earned $24.90 billion during the quarter, compared to analysts’ expectations of $26.31 billion. During the same quarter last year, the firm posted $1.56 earnings per share. The company’s revenue for the quarter was down 5.0% compared to the same quarter last year. On average, equities research analysts forecast that Express Scripts Holding Company will post $6.93 EPS for the current year.
In other Express Scripts Holding Company news, VP Everett Neville sold 1,123 shares of the firm’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $69.41, for a total value of $77,947.43. Following the completion of the sale, the vice president now owns 12,712 shares of the company’s stock, valued at $882,339.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.54% of the company’s stock.
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).